title: Pharmacological targeting of eIF4E in primary CLL lymphocytes.
authors.affiliation: Department of Oncology & Division of Experimental Medicine, Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada.
authors.forename: V
authors.initials: V
authors.lastname: Martinez-Marignac
authors.forename: M
authors.initials: M
authors.lastname: Shawi
authors.forename: E
authors.initials: E
authors.lastname: Pinedo-Carpio
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: L
authors.initials: L
authors.lastname: Panasci
authors.forename: W
authors.initials: W
authors.lastname: Miller
authors.forename: F
authors.initials: F
authors.lastname: Pettersson
authors.forename: R
authors.initials: R
authors.lastname: Aloyz
references.citation: Nature. 2004 Mar 18;428(6980):332-7
references.pmid: 15029198
references.citation: Leukemia. 2002 Jun;16(6):1015-27
references.pmid: 12040433
references.citation: Differentiation. 2002 Mar;70(1):10-22
references.pmid: 11963652
references.citation: Mol Pharmacol. 2010 Oct;78(4):778-84
references.pmid: 20664001
references.citation: Blood. 2006 Aug 15;108(4):1334-8
references.pmid: 16670263
references.citation: Cancer Res. 2010 Sep 15;70(18):7336-44
references.pmid: 20823161
references.citation: Blood. 2011 Sep 29;118(13):3603-12
references.pmid: 21803855
references.citation: Oncotarget. 2012 Feb;3(2):118-31
references.pmid: 22392765
references.citation: Blood. 2013 May 2;121(18):3675-81
references.pmid: 23509154
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18105-10
references.pmid: 15601771
references.citation: Leukemia. 2011 Jul;25(7):1197-200
references.pmid: 21455212
references.citation: Cancer Res. 2008 Feb 1;68(3):631-4
references.pmid: 18245460
references.citation: Blood. 2009 Jul 9;114(2):257-60
references.pmid: 19433856
references.citation: Curr Opin Cell Biol. 1998 Apr;10(2):268-75
references.pmid: 9561852
references.citation: Int J Cancer. 2013 Jul;133(1):247-52
references.pmid: 23238639
references.citation: Clin Cancer Res. 2011 May 1;17(9):2874-84
references.pmid: 21415224